Spire Healthcare Group PLC Notice of Interim Results (8388I)
August 10 2023 - 1:00AM
UK Regulatory
TIDMSPI
RNS Number : 8388I
Spire Healthcare Group PLC
10 August 2023
Spire Healthcare Group plc
('Spire Healthcare', 'the Company' or 'the Group')
Notice of Interim Results
10 August 2023
Spire Healthcare Group plc (LSE: SPI), a leading independent
healthcare group in the UK, will announce its interim results for
the six months ended 30 June 2023 on Thursday, 14 September
2023.
A presentation for sell-side analysts and investors will be held
on the day of the interim results announcement at 9:00 am (BST) at
the offices of Instinctif Partners, 65 Gresham Street, London, EC2V
7NQ. Refreshments will be available from 8.30 am. If you would like
to register your interest in attending the presentation in person,
please contact Instinctif Partners at spire@instinctif.com .
Following the presentation, there will be a moderated Q&A
session.
For those who cannot attend in person, the presentation will
also be accessible via live Zoom webcast.
Click the following link to register in advance for the Zoom
webcast and to receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_OPdXNsztQf-dpAJW5qbIFw
A recording of the webcast will be made available from 1.00 pm
on 14 September on the Spire Healthcare website,
https://www.investors.spirehealthcare.com
- Ends -
For further information please contact:
Spire Healthcare
Angus Prentice - Director of Investor
Relations +44 (0)7974 982 512
Instinctif Partners
Damian Reece +44 (0)7931 598 593
Guy Scarborough +44 (0)7917 178 920
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent healthcare group in
the United Kingdom, with 39 hospitals and 33 clinics, medical
centres and consulting rooms across England, Wales and Scotland. It
operates a network of private GPs and provides occupational health
services to over 700 corporate clients.
Working in partnership with over 8,760 experienced consultants,
Spire Healthcare delivered tailored, personalised care to
approximately 926,500 inpatients, outpatients and day-case patients
in 2022, and is the leading private provider, by volume, of knee
and hip operations in the United Kingdom. The Group's well-located
and scalable hospitals have delivered successful and award-winning
clinical outcomes, positioning the Group well with patients,
consultants, the NHS, GPs and Private Medical Insurance (PMI)
providers. 98% of Spire Healthcare's inspected hospitals and
clinics are rated 'Good', 'Outstanding' or the equivalent by health
inspectors in England, Scotland and Wales.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORXKLFBXVLXBBQ
(END) Dow Jones Newswires
August 10, 2023 02:00 ET (06:00 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From May 2023 to May 2024